Ubix Therapeutics | ApexOnco - Clinical Trials news and analysis

x

“Top quality, fast and so easy to use”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Data insights

2 October 2024

BeiGene tries where others failed

The company’s CEACAM5 and PRMT5 projects feature among the latest first-in-human entrants.

Subscribe to Ubix Therapeutics